Synopsis
The applicant, a 55-year-old CEO of a Department of War contractor, faced security concerns under Guideline H due to his admitted use and purchase of tetrahydrocannabinol (THC) from August 2021 to September 2025. Despite his claims of therapeutic use and recent abstinence, the judge found that the applicant's drug involvement raised significant questions about his reliability and trustworthiness, leading to a denial of his security clearance application.
Why the Applicant Was Denied
- The applicant admitted to using and purchasing THC, which is a Schedule I controlled substance under federal law.
- The applicant continued to use marijuana after being informed of its illegal status and the implications for security clearance eligibility.
- The applicant had marijuana in his residence at the time of the hearing, indicating ongoing drug involvement.
Conditions Referenced
- AG ¶ 25(a)appliedSubstance Misuse
- AG ¶ 25(c)appliedIllegal Possession of a Controlled Substance
Key Rule Quoted
“"Any doubt concerning personnel being considered for access to classified information will be resolved in favor of the national security."”
Procedural Posture
- SOR issuedDec 4, 2025
- Answer filedJan 8, 2026
- Hearing heldMar 31, 2026conducted by video teleconference
- Decision dateApr 17, 2026
Cite For
- Denial of Security Clearance Due to Ongoing Drug Involvement Under Guideline H
- Impact of Federal Drug Laws on Security Clearance Eligibility
- Importance of Demonstrating a Pattern of Abstinence From Controlled Substances